05/19/2024
11:15 PM | CNS Pharmaceuticals (Filer)
| Form EFFECT | |
05/16/2024
9:56 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
4:00 PM | CNS Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
4:28 PM | CNS Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/07/2024
4:00 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
5:37 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
8:50 PM | Charles Faith L. (Reporting)
CNS Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/10/2024
8:50 PM | Climaco John M (Reporting)
CNS Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:51 PM | CNS Pharmaceuticals (Issuer)
Cockroft Bettina M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:51 PM | CNS Pharmaceuticals (Issuer)
Downs Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:52 PM | CNS Pharmaceuticals (Issuer)
Evans Carl Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:52 PM | CNS Pharmaceuticals (Issuer)
Gumulka Jerzy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:52 PM | CNS Pharmaceuticals (Issuer)
Keyes Jeffry R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:53 PM | CNS Pharmaceuticals (Issuer)
Mahery Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
6:40 PM | CNS Pharmaceuticals (Filer)
| Form DEF 14A | |
03/28/2024
4:27 PM | CNS Pharmaceuticals (Filer)
| Form PRE 14A | |
02/14/2024
1:25 PM | ARMISTICE CAPITAL, LLC (Filed by)
CNS Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/06/2024
9:26 AM | CNS Pharmaceuticals (Issuer)
Mahery Amy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2024
9:27 AM | Climaco John M (Reporting)
CNS Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
9:27 AM | CNS Pharmaceuticals (Issuer)
Downs Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
9:27 AM | CNS Pharmaceuticals (Issuer)
Evans Carl Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
9:28 AM | CNS Pharmaceuticals (Issuer)
Gumulka Jerzy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
9:28 AM | CNS Pharmaceuticals (Issuer)
Mahery Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:00 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
3:27 PM | CNS Pharmaceuticals (Filer)
| Form 424B4 | |
01/29/2024
11:15 PM | CNS Pharmaceuticals (Filer)
| Form EFFECT | |
01/23/2024
3:01 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2024
5:02 AM | CNS Pharmaceuticals (Filer)
| Form S-1/A | |
01/10/2024
4:26 PM | CNS Pharmaceuticals (Filer)
| Form S-1/A | |
12/21/2023
8:15 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
7:36 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
4:28 PM | CNS Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
11/30/2023
11:15 PM | CNS Pharmaceuticals (Filer)
| Form EFFECT | |
11/30/2023
4:20 PM | CNS Pharmaceuticals (Filer)
| Form 424B3 | |
11/21/2023
8:11 PM | CNS Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/20/2023
4:26 PM | CNS Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/15/2023
7:00 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
8:00 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2023
7:00 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
5:00 PM | Andraczke Andrzej (Reporting)
CNS Pharmaceuticals (Issuer)
| Form 4/A | |
10/12/2023
5:00 PM | Charles Faith L. (Reporting)
CNS Pharmaceuticals (Issuer)
| Form 4/A | |
Log Into Marc's $5,000 System Today (Ad) New Panic Could Sweep America
Mark these words in 2024. Everyone's going to cash… Wall Street legend says: "A little-known vehicle outside of banks could double… triple… or even quadruple your life savings if you know where to find it right now." We urge you to move your cash into this vehicle in 2024.  More here. |
10/12/2023
5:00 PM | CNS Pharmaceuticals (Issuer)
Cockroft Bettina M. (Reporting)
| Form 4/A | |
10/12/2023
5:01 PM | CNS Pharmaceuticals (Issuer)
Keyes Jeffry R. (Reporting)
| Form 4/A | |
10/12/2023
5:01 PM | CNS Pharmaceuticals (Issuer)
Evans Carl Anthony (Reporting)
| Form 4/A | |
10/12/2023
5:01 PM | CNS Pharmaceuticals (Issuer)
Gumulka Jerzy (Reporting)
| Form 4/A | |
09/25/2023
5:20 PM | Andraczke Andrzej (Reporting)
CNS Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
5:20 PM | Charles Faith L. (Reporting)
CNS Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
5:21 PM | CNS Pharmaceuticals (Issuer)
Cockroft Bettina M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
5:24 PM | CNS Pharmaceuticals (Issuer)
Evans Carl Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
5:26 PM | CNS Pharmaceuticals (Issuer)
Gumulka Jerzy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
5:27 PM | CNS Pharmaceuticals (Issuer)
Keyes Jeffry R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
6:51 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2023
7:00 AM | CNS Pharmaceuticals (Issuer)
Downs Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
4:25 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2023
7:30 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
4:12 PM | CNS Pharmaceuticals (Filer)
| Form DEF 14A | |
08/14/2023
8:25 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
6:34 AM | CNS Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
8:14 PM | CNS Pharmaceuticals (Issuer)
Cockroft Bettina M. (Reporting)
| Form 4/A | |
